Cover Image

EFFICACY AND SAFETY OF INCLISIRAN BY BASELINE BODY MASS INDEX: A POST HOC POOLED ANALYSIS OF THE ORION-9, ORION-10 AND ORION-11 PHASE III RANDOMIZED CONTROLLED TRIALS

Therapeutic Area: ASCVD/CVD Risk Factors Background: Excessive bodyweight, often associated with dyslipidemia, may affect the pharmacology of drugs. Inclisiran, a small interfering RNA targeting PCSK9 hepatic mRNA, is an effective LDL-C lowering agent with twice-yearly subcutaneous dosing (after the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lawrence A Leiter (Author), David G Kallend (Author), Wolfgang Koenig (Author), Ulf Landmesser (Author), Kausik K Ray (Author), Gregory G Schwartz (Author), R Scott Wright (Author), YannTong Chiang (Author), Lorena Garcia Conde Orozco (Author), Frederick J Raal (Author)
Format:	Book
Published:	Elsevier, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11
by: Wolfgang Koenig, et al.
Published: (2023)

The Five Hells of Orion
by: Pohl, Frederik, 1919-2013; Schelling, George, 1938- [Illustrator]

The Death From Orion
by: Matthews, W. J. (William J.)

Local and Systemic Oxidative Stress Biomarkers for Male Infertility: The ORION Study
by: Anna T. Bergsma, et al.
Published: (2022)

Comparison of inhibitory dilutions of a thymol-based mouthwash (Orion®) with chlorhexidine on Streptococcus mutans and Streptococcus sanguis
by: Shokrollah Assar, et al.
Published: (2011)

A workforce survey of Australian osteopathy: analysis of a nationally-representative sample of osteopaths from the Osteopathy Research and Innovation Network (ORION) project
by: Jon Adams, et al.
Published: (2018)

O papel social da Escola Estadual Dom Orione (Curitiba/PR) e as políticas nacionais e estaduais de educação (1967a 1971)
by: Gabriel Fernandes da Silva, et al.
Published: (2023)

Multifaceted ORganizational InterventiONs (M-ORION) project for prevention of depression and anxiety among workers: study protocol for a five-arm cluster randomized controlled trial
by: Kazuhiro Watanabe, et al.
Published: (2024)

Inclisiran for the treatment of hypercholesterolaemia
by: Joel C Marrs, et al.
Published: (2024)

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study
by: David Kallend, et al.
Published: (2022)

Inclisiran - hope in the fight against dyslipidemia
by: Paulina Krawiec, et al.
Published: (2023)

The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions
by: Dario Lehoux, et al.
Published: (2023)

BASELINE CHARACTERISTICS OF PARTICIPANTS ENROLLED IN VICTORION-INCEPTION: A RANDOMIZED STUDY OF INCLISIRAN VS. USUAL CARE IN PATIENTS WITH RECENT HOSPITALIZATION FOR AN ACUTE CORONARY SYNDROME
by: Kirk U Knowlton, MD
Published: (2024)

ONE YEAR EXPERIENCE WITH INCLISIRAN IN AN ACADEMIC LIPID CLINIC:
by: Tommy T. Chiou, BA, et al.
Published: (2023)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023)

Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
by: Łukasz Wołowiec, et al.
Published: (2023)

Inclisiran: a new generation of lipid-lowering siRNA therapeutic
by: Yanzhen Zhang, et al.
Published: (2023)

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database
by: Giuseppe Cicala, et al.
Published: (2024)

THE POTENTIAL DANGER TO ASCVD RISK REDUCTION: A RARE CASE OF INCLISIRAN INDUCED VASCULITIS
by: Sumair Ozair, DO
Published: (2024)

Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential
by: Kosmas CE, et al.
Published: (2020)

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
by: Lidia Oostvogels, et al.
Published: (2019)

Recent Developments on Mobile Ad-Hoc Networks and Vehicular Ad-Hoc Networks
Published: (2021)

Ad Hoc Networks
Published: (2017)

Revisores ad hoc
by: admin Débora Diersmann
Published: (2012)

Consultores ad hoc
by: Revista Perspectiva
Published: (2021)

Revisores ad hoc
by: admin Débora Diersmann
Published: (2013)

Avaliadores Ad Hoc
by: Gilmara Ribeiro Santos Rodrigues
Published: (2016)

Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies
by: Kelly E. Duncan, et al.
Published: (2024)

New possibilities for lipid level control using inclisiran - prospects for interaction between a cardiologist and a neurologist
by: A. B. Skiba, et al.
Published: (2023)

The City by the Pool Assessing the Archaeology of the City of Lincoln
by: Vince, Alan G.
Published: (2003)

The City by the Pool Assessing the Archaeology of the City of Lincoln
by: Vince, Alan G.
Published: (2003)

Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms
by: Yoshiteru Takekita, et al.
Published: (2024)

Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II
by: Alexandra B. Kimball, et al.
Published: (2018)

Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets
by: Franke RM, et al.
Published: (2015)

The combination use of inclisiran and statins versus statins alone in the treatment of dyslipidemia in mainland China: a cost-effectiveness analysis
by: Wenjing Zhou, et al.
Published: (2024)

Efficacy and safety of inclisiran in stroke or cerebrovascular disease prevention: a systematic review and meta-analysis of randomized controlled trials
by: Min Luo, et al.
Published: (2023)

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review
by: Iveta Merćep, et al.
Published: (2022)

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial
by: Shangying Hu, et al.
Published: (2021)

Ackowledgements the ad hoc experts
by: Agradecimentos aos especialistas ad hoc
Published: (2016)

Consultores Ad Hoc 2022
by: Revista Perspectiva
Published: (2022)